33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center
    Meeting Abstract

    Dennehy, C.; Mullally, W.; Goggin, C.; Gleeson, J. P.; Greene, J. P.; Power, D. G.; O'Reilly, S.; Collins, D. C.; O'Mahony, D.; Bambury, R. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • IPATunity130: A pivotal randomized phase III trial evaluating ipatasertib (IPAT) + paclitaxel (PAC) for PIK3CA/AKT1/PTEN-altered advanced triple-negative (TN) or hormone receptor-positive HER2-negative (HR+/HER2-) breast cancer (BC)
    Meeting Abstract

    Dent, R.; Kim, S. B.; Oliveira, M.; Isakoff, S. J.; Barrios, C. H.; O'Shaughnessy, J.; Lu, X.; Wongchenko, M.; Bradley, D.; Mani, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Overall survival (OS) update of the double-blind placebo (PBO)-controlled randomized phase 2 LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for locally advanced/metastatic triple-negative breast cancer (mTNBC)
    Meeting Abstract

    Dent, R.; Im, S. A.; Espie, M.; Blau, S.; Tan, A. R.; Isakoff, S. J.; Oliveira, M.; Saura, C.; Wongchenko, M.; Kapp, A. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Bridging the gap in global advanced radiation oncology training: Impact of a web-based open-access interactive three-dimensional contouring atlas on radiation oncology practice in Russia
    Meeting Abstract

    Dengina, N.; McClelland, S.; Chernich, M.; Gillespie, E. F.; Likhacheva, A.; Usychkin, S.; Pankratov, A.; Kharitonova, E.; Egorova, Y.; Tsimafeyeu, I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC)
    Meeting Abstract

    Das, R. K.; Furchtgott, L.; Meyerhardt, J. A.; Nixon, A. B.; Innocenti, F.; Cunha, D.; Rich, K.; Lenz, H. J.; Niedzwiecki, D.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ramucirumab (RAM) exposure-response (ER) relationship in RANGE, a randomized phase III trial of docetaxel (DOC) with or without RAM in advanced urothelial carcinoma (UC) patients (pts) who progressed on or after platinum therapy
    Meeting Abstract

    De Wit, R.; Powles, T.; Castellano, D. E.; Necchi, A.; Lee, J. L.; Van Der Heijden, M. S.; Matsubara, N.; Bamias, A.; Flechon, A.; Sternberg, C. N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognosis of resectable pancreatic cancer based on systemic therapy sequence and regimen: An NCDB analysis
    Meeting Abstract

    Deng, A.; Wang, C.; Cohen, S. J.; Winter, J. M.; Mallick, A. B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Emergency department (ED) presenting symptom clusters for chemotherapy patients
    Meeting Abstract

    Daly, R. M.; Nicholas, K.; Gorenshteyn, D.; Sokolowski, S.; Gazit, L.; Adams, L.; Matays, J.; Katzen, L. L.; Chiu, O. O.; Xiao, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cancer pain in the emergency department: A multicenter study of the Comprehensive Oncologic Emergencies Research Network
    Meeting Abstract

    Coyne, C. J.; Shatsky, R. A.; Durham, D. D.; Klotz, A.; Bastani, A.; Baugh, C.; Grudzen, C.; Henning, D.; Adler, D.; Wilson, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia in the BFORE trial: 24-month follow-up
    Meeting Abstract

    Cortes, J. E.; Mauro, M. J.; Deininger, M. W. N.; Chuah, C.; Kim, D. W.; Kota, V.; Lipton, J. H.; Rousselot, P. H.; Milojkovic, D.; Le Coutre, P. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save